Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network AnalysisPadhmanand Sudhakar, Séverine Vermeire, Bram Verstockt et al.|Inflammatory Bowel Diseases|2020Cited by 50
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype EquilibriumBrecht Creyns, Christine Breynaert, Inge Jacobs et al.|Frontiers in Immunology|2020Cited by 40
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Christine Breynaert, Clémentine Perrier et al.|Frontiers in Immunology|2018Cited by 24
Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBDBram Verstockt, Padhmanand Sudhakar, Sare Verstockt et al.|BMJ Open Gastroenterology|2023Cited by 19
DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's diseaseBram Verstockt, Marc Ferrante, P Sudahakar et al.|Journal of Crohn s and Colitis|2019Cited by 12